Gene · 6510
Papers3,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy. | BMC Cancer | 2025 | 39875895 | PubTator, text mining | PubMed |
| SLC1A5 is a key regulator of glutamine metabolism and a prognostic marker for aggressive luminal breast cancer. | Sci Rep | 2025 | 39843491 | PubTator, text mining | PubMed |
| Mechanism Study of E2F8 Activation of SPC25-Mediated Glutamine Metabolism Promoting Immune Escape in Lung Adenocarcinoma. | Immunology | 2025 | 39829079 | PubTator, text mining | PubMed |
| DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma. | Dev Cell | 2025 | 39798576 | PubTator, text mining | PubMed |
| RTN4IP1 Contributes to ESCC via Regulation of Amino Acid Transporters. | Adv Sci (Weinh) | 2025 | 39757767 | PubTator, text mining | PubMed |
| CD44v, S1PR1, HER3, MET and cancer-associated amino acid transporters are promising targets for the pancreatic cancers characterized using mAb. | FEBS Open Bio | 2025 | 39757718 | PubTator, text mining | PubMed |
| ATF4 promotes glutaminolysis and glycolysis in colorectal cancer by transcriptionally inducing SLC1A5. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 39696988 | PubTator, text mining | PubMed |
| Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency. | Adv Sci (Weinh) | 2025 | 39680480 | PubTator, text mining | PubMed |
| Scutellarein inhibits lung cancer growth by inducing cell apoptosis and inhibiting glutamine metabolic pathway. | J Ethnopharmacol | 2025 | 39490431 | PubTator, text mining | PubMed |
| Clinical and histopathological factors for recurrence and metastasis in lacrimal gland adenoid cystic carcinoma in Chinese patients. | Eur J Ophthalmol | 2025 | 38689460 | PubTator, text mining | PubMed |
| Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer. | J Adv Res | 2025 | 38432394 | PubTator, text mining | PubMed |
| Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia. | Curr Pharmacol Rep | 2024 | 40756330 | PubTator, text mining | PubMed |
| CRL3 E3 ligase regulates glutamine and cystine metabolisms. | Protein Cell | 2024 | 40440083 | PubTator, text mining | PubMed |
| Association between folate and glutamine metabolism and prognosis of kidney cancer. | Front Nutr | 2024 | 39958609 | PubTator, text mining | PubMed |
| Identification of potential biomarkers from amino acid transporter in the activation of hepatic stellate cells via bioinformatics. | Front Genet | 2024 | 39698464 | PubTator, text mining | PubMed |
| Microenvironmental G protein-coupled estrogen receptor-mediated glutamine metabolic coupling between cancer-associated fibroblasts and triple-negative breast cancer cells governs tumour progression. | Clin Transl Med | 2024 | 39690134 | PubTator, text mining | PubMed |
| Engineered packaging cell line for the enhanced production of baboon-enveloped retroviral vectors. | Mol Ther Nucleic Acids | 2024 | 39679008 | PubTator, text mining | PubMed |
| Asparagine availability controls germinal center B cell homeostasis. | Sci Immunol | 2024 | 39671468 | PubTator, text mining | PubMed |
| KLF7 Promotes Hepatocellular Carcinoma Progression Through Regulating SLC1A5-Mediated Tryptophan Metabolism. | J Cell Mol Med | 2024 | 39648156 | PubTator, text mining | PubMed |
| Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma. | BMC Cancer | 2024 | 39639273 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6510/papers?page=11